Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05666258 | Gene Expression Profiling to Help Define the Need for Neo-Adjuvant Chemotherapy in HR+, HER- Breast Cancer Patients(NACAGEP) | completed | — | 22 | Universitair Ziekenhuis BrusselOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT06219187 | Male breAsT cAncer preDisposition Factor(MATADOR) | completed | — | 93 | Institut Claudius RegaudOTHER | 1 |
| Jun 10, 2026 |
| clinicaltrials |
| NCT06253195 | BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors | completed | Phase 1 | 33 | BeOne MedicinesINDUSTRY | 1 | Jun 10, 2026 | clinicaltrials |
| NCT03051828 | Physical Evaluation and Quality of Life in the Practice of Fencing in Breast Cancer Support(ESCRIME) | completed | — | 30 | Hôpital NOVOOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT06513364 | Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer | completed | Phase 2 | 40 | Beijing Wehand-Bio Pharmaceutical Co., LtdINDUSTRY | 1 | Jun 9, 2026 | clinicaltrials |
| NCT07636096 | Breast Phyllodes Tumors: Based on 20-year Real-world Data From China | completed | — | 3,500 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT00314405 | Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope | completed | N/A | 100 | University Hospital, Strasbourg, FranceOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT03289962 | A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors | completed | Phase 1 | 273 | Genentech, Inc.INDUSTRY | 8 | Jun 8, 2026 | clinicaltrials |
| NCT05856656 | Music Therapy as a Tool for Anxiety Reduction in Localized Breast Cancer(CENSORIAL) | completed | N/A | 27 | Institut Cancerologie de l'OuestOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07320521 | A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects. | completed | Phase 1 | 6 | Shandong Suncadia Medicine Co., Ltd.INDUSTRY | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07631962 | Impact of Radiotherapy on Survival in Breast Cancer Patients | completed | — | 1,030 | Motamed Cancer InstituteOTHER | 0 | Jun 8, 2026 | clinicaltrials |
| NCT06570031 | ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer | completed | Phase 1 | 46 | Ono Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 5, 2026 | clinicaltrials |
| NCT03975959 | Memory Perception Assessment in Central/Non-central Nervous System Cancers(PROMESSE) | completed | N/A | 426 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT05946668 | Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study | completed | — | 35 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT06455657 | Breast Cancer Education to Prisoner Women | completed | N/A | 40 | Hitit UniversityOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT06710990 | Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer | completed | Phase 1 | 17 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jun 4, 2026 | clinicaltrials |
| NCT05623397 | A Deep Learning Method to Evaluate QT on Ribociclib(QT-RIBRATING) | completed | — | 70 | CMC Ambroise ParéOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT04418856 | The Effects of Light Therapy to Treat Cancer-related Side Effects | completed | N/A | 260 | Reykjavik UniversityOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT05038137 | Time Restricted Eating on Cancer Risk(TREC) | completed | N/A | 29 | Medical University of South CarolinaOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT05505175 | Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC | completed | — | 121 | PfizerINDUSTRY | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06624020 | A Study to Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic Breast Cancer in Australia(ROSIE) | completed | — | 1,128 | PfizerINDUSTRY | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06767059 | The Effect of Walking and Grounding in Women With Breast Cancer | completed | N/A | 55 | Ankara UniversityOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06106165 | Improving Muslim Women's Uptake of Cancer Screening (IMCAN)(IMCAN) | completed | N/A | 169 | University of SunderlandOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT06940310 | Different Resistance Training Intensity Prescription and Monitoring Methodologies: Effects on Strength, Body Composition, and Well-being in Survivors of Breast Cancer | completed | N/A | 61 | Universidad de AlmeriaOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT03712813 | Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors | completed | N/A | 72 | Indiana UniversityOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT06300411 | SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery | completed | Phase 1 | 25 | SURGE TherapeuticsINDUSTRY | 1 | May 28, 2026 | clinicaltrials |
| NCT07148336 | Identification of Chemotherapy-induced Peripheral Neuropathy(NEURO-BREAC) | completed | N/A | 26 | University Hospital Schleswig-HolsteinOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT00600496 | A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) | completed | Phase 1 | 140 | AstraZenecaINDUSTRY | 1 | May 27, 2026 | clinicaltrials |
| NCT04107636 | Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance(MINIVAB) | completed | N/A | 45 | Radboud University Medical CenterOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT05181462 | Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.(TRIFOUR) | completed | Phase 1 / Phase 2 | 117 | Cantargia ABINDUSTRY | 1 | May 27, 2026 | clinicaltrials |
| NCT05955833 | 89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study(HER Image) | completed | N/A | 6 | Amsterdam UMC, location VUmcOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT06461663 | CairnSurgical Breast Cancer Locator (BCL) Post-Market Study | completed | N/A | 35 | CairnSurgical, Inc.INDUSTRY | 3 | May 27, 2026 | clinicaltrials |
| NCT06619873 | A Clinical Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects | completed | Phase 1 | 24 | Shandong Suncadia Medicine Co., Ltd.INDUSTRY | 1 | May 27, 2026 | clinicaltrials |
| NCT04296162 | Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)(ORCHID) | completed | Phase 2 | 182 | Fudan UniversityOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT07607548 | Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer | completed | N/A | 60 | Poznan University of Medical SciencesOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT03789097 | Vaccination With Flt3L, Radiation, and Poly-ICLC | completed | Phase 1 / Phase 2 | 17 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT04489173 | TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer(TIBET) | completed | Phase 2 | 52 | Borstkanker Onderzoek GroepNETWORK | 1 | May 22, 2026 | clinicaltrials |
| NCT04651452 | Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors | completed | N/A | 250 | Carnegie Mellon UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT04699630 | A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer | completed | Phase 2 | 121 | SCRI Development Innovations, LLCOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT04764292 | Screening Contrast-Enhanced Mammography as an Alternative to MRI(SCEMAM) | completed | Phase 4 | 615 | Wendie BergOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06188559 | A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer | completed | Phase 2 | 56 | Eisai Inc.INDUSTRY | 4 | May 22, 2026 | clinicaltrials |
| NCT05900986 | LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer | completed | Phase 1 / Phase 2 | 22 | Integro TheranosticsINDUSTRY | 1 | May 20, 2026 | clinicaltrials |
| NCT05146297 | Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials(DISRUPT) | completed | N/A | 585 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT05984914 | Stress Management and Biological Age in Breast Cancer Patients.RCT | completed | N/A | 120 | Maria CharalampopoulouOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT06018038 | Arm Exercise Capacity and Maximal Oxygen Consumption With Breast Cancer | completed | — | 60 | Hacettepe UniversityOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT07596459 | Hybrıd Educatıon Based on Psychodynamıc Nursıng Theory of Women Undergoıng Mastectomy(Mastectomy) | completed | N/A | 69 | Karadeniz Technical UniversityOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT05871125 | Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial Toxicity | completed | N/A | 39 | University of Alabama at BirminghamOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07101861 | Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools): A Pilot, Feasibility Study(RESET) | completed | N/A | 37 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 18, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jun 10, 2026source: clinicaltrials